The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
Giovanni GuaraldiJovana MilicStefano RenzettiFederico MottaFelice CinqueJenny BischoffAndrea DesilaniJacopo ContiFilippo MedioliMartina Del MonteDana KablawiWesal ElgretliStefano CalzaCristina MussiniJuergen K RockstrohGiada SebastianiPublished in: AIDS (London, England) (2024)
Fibrosis transitions are driven by metabolic health variables in PWH, independently of viral hepatitis coinfection and antiretroviral class therapy.
Keyphrases
- liver fibrosis
- weight gain
- hiv infected
- hiv positive
- human immunodeficiency virus
- body mass index
- hiv aids
- antiretroviral therapy
- birth weight
- healthcare
- public health
- hepatitis c virus
- sars cov
- hiv infected patients
- oxidative stress
- weight loss
- hiv testing
- health information
- mesenchymal stem cells
- stem cells
- preterm birth